Demyelinating disorders

Peter A. Arnett; Margaret Cadden

doi:10.1016/B978-0-323-91497-0.00234-4

Demyelinating disorders

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Mental health problems are extremely common in persons with multiple sclerosis (PwMS), especially depression and anxiety. Clinically diagnosable depression occurs in about 50% of PwMS over their lifetimes, compared with only about the 8% to 20% reported for the general population. Anxiety has been less well-studied, but it has also been found to be very common, with recent studies suggesting that about 40% of PwMS experience clinically significant anxiety at any given time. In this article, we review factors that may contribute to anxiety and depression in MS. We also discuss some treatment research and provide guidelines for future investigations that may explore these salient and debilitating mental health problems in MS.

Original language	English (US)
Title of host publication	Encyclopedia of Mental Health, Third Edition
Subtitle of host publication	Volume 1-3
Publisher	Elsevier
Pages	V1-600-V1-607
Volume	1
ISBN (Electronic)	9780323914987
ISBN (Print)	9780323914970
DOIs	https://doi.org/10.1016/B978-0-323-91497-0.00234-4
State	Published - Jan 1 2023

All Science Journal Classification (ASJC) codes

General Psychology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/B978-0-323-91497-0.00234-4

Cite this

@inbook{edb4e4c825844fb3930d19c47fdc3fd4,

title = "Demyelinating disorders",

abstract = "Mental health problems are extremely common in persons with multiple sclerosis (PwMS), especially depression and anxiety. Clinically diagnosable depression occurs in about 50% of PwMS over their lifetimes, compared with only about the 8% to 20% reported for the general population. Anxiety has been less well-studied, but it has also been found to be very common, with recent studies suggesting that about 40% of PwMS experience clinically significant anxiety at any given time. In this article, we review factors that may contribute to anxiety and depression in MS. We also discuss some treatment research and provide guidelines for future investigations that may explore these salient and debilitating mental health problems in MS.",

author = "Arnett, {Peter A.} and Margaret Cadden",

year = "2023",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-91497-0.00234-4",

language = "English (US)",

isbn = "9780323914970",

volume = "1",

pages = "V1--600--V1--607",

booktitle = "Encyclopedia of Mental Health, Third Edition",

publisher = "Elsevier",

address = "Netherlands",

}

TY - CHAP

T1 - Demyelinating disorders

AU - Arnett, Peter A.

AU - Cadden, Margaret

PY - 2023/1/1

Y1 - 2023/1/1

N2 - Mental health problems are extremely common in persons with multiple sclerosis (PwMS), especially depression and anxiety. Clinically diagnosable depression occurs in about 50% of PwMS over their lifetimes, compared with only about the 8% to 20% reported for the general population. Anxiety has been less well-studied, but it has also been found to be very common, with recent studies suggesting that about 40% of PwMS experience clinically significant anxiety at any given time. In this article, we review factors that may contribute to anxiety and depression in MS. We also discuss some treatment research and provide guidelines for future investigations that may explore these salient and debilitating mental health problems in MS.

AB - Mental health problems are extremely common in persons with multiple sclerosis (PwMS), especially depression and anxiety. Clinically diagnosable depression occurs in about 50% of PwMS over their lifetimes, compared with only about the 8% to 20% reported for the general population. Anxiety has been less well-studied, but it has also been found to be very common, with recent studies suggesting that about 40% of PwMS experience clinically significant anxiety at any given time. In this article, we review factors that may contribute to anxiety and depression in MS. We also discuss some treatment research and provide guidelines for future investigations that may explore these salient and debilitating mental health problems in MS.

UR - http://www.scopus.com/inward/record.url?scp=85168894921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85168894921&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-91497-0.00234-4

DO - 10.1016/B978-0-323-91497-0.00234-4

M3 - Chapter

AN - SCOPUS:85168894921

SN - 9780323914970

VL - 1

SP - V1-600-V1-607

BT - Encyclopedia of Mental Health, Third Edition

PB - Elsevier

ER -

Demyelinating disorders

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this